Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Elevai Labs, Inc. - Common Stock
(NQ:
ELAB
)
2.560
+0.210 (+8.94%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,263,593
Open
2.570
Bid (Size)
2.450 (1)
Ask (Size)
2.500 (9)
Prev. Close
2.350
Today's Range
2.080 - 2.700
52wk Range
1.740 - 778.00
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Elevai Labs Inc. Announces Name Change to PMGC Holdings Inc. and Redomicile to Nevada
December 20, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Inc. Announces Anticipated Name Change to PMGC Holdings Inc. and Redomicile to Nevada
December 20, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Performance
YTD
-99.32%
-99.32%
1 Month
-36.63%
-36.63%
3 Month
-87.97%
-87.97%
6 Month
-97.81%
-97.81%
1 Year
-99.30%
-99.30%
More News
Read More
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
December 19, 2024
Via
Benzinga
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Announces FDA Regulatory Pathway for EL-22, a Pioneering Obesity Therapy Targeting Fat Loss and Muscle Preservation
December 09, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry into Hair Care Market
December 06, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division
December 04, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Why Uxin Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
November 25, 2024
Via
Benzinga
Elevai Labs Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance
November 22, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Inc. Announces Withdrawal of Offer to Exchange and Plans to Reassess
November 22, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
CORRECTION - Elevai Labs Inc.
November 14, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
US Stocks Edge Lower; Cisco Earnings Top Views
November 14, 2024
Via
Benzinga
Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business Update
November 14, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
November 14, 2024
Via
Benzinga
MicroCaps Making Major Moves: DJT, BNOX, ELAB, PETV, RJDG in High-Growth Markets
November 05, 2024
Via
AB Newswire
Topics
Government
Exposures
Political
Why Palantir Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
November 05, 2024
Via
Benzinga
Elevai Labs Inc. Announces Update and Extension of Pending Offer to Exchange
November 04, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Dow Jumps 400 Points; US Adds 12,000 Jobs In October
November 01, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
November 01, 2024
Via
Benzinga
Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
October 31, 2024
Via
Benzinga
12 Consumer Staples Stocks Moving In Friday's Intraday Session
October 25, 2024
Via
Benzinga
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity
October 22, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of Obesity
October 21, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
12 Consumer Staples Stocks Moving In Thursday's After-Market Session
October 10, 2024
Via
Benzinga
Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred Stock
October 04, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
12 Consumer Staples Stocks Moving In Friday's After-Market Session
October 04, 2024
Via
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.